Cargando…
Public opinion of a stroke clinical trial using exception from informed consent
BACKGROUND: Acute stroke is a leading cause of morbidity and mortality. Clinical trials in stroke are challenging because victims often do not have the capacity to provide informed consent, excluding those patients most likely to benefit from the research. AIM: We evaluated patient willingness to pa...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047845/ https://www.ncbi.nlm.nih.gov/pubmed/21373310 http://dx.doi.org/10.1007/s12245-010-0244-2 |
_version_ | 1782199081670541312 |
---|---|
author | Goldstein, Joshua N. Espinola, Janice A. Fisher, Jonathan Pallin, Daniel J. Camargo, Carlos A. |
author_facet | Goldstein, Joshua N. Espinola, Janice A. Fisher, Jonathan Pallin, Daniel J. Camargo, Carlos A. |
author_sort | Goldstein, Joshua N. |
collection | PubMed |
description | BACKGROUND: Acute stroke is a leading cause of morbidity and mortality. Clinical trials in stroke are challenging because victims often do not have the capacity to provide informed consent, excluding those patients most likely to benefit from the research. AIM: We evaluated patient willingness to participate in a hypothetical acute stroke trial using an exception from informed consent. METHODS: Consecutive patients presenting to four emergency departments (EDs) underwent structured interviews regarding a hypothetical stroke trial using an exception from informed consent. RESULTS: Of 461 (72% of eligible) participants, 55% (95% CI, 50%–59%) were willing to be enrolled in the hypothetical study without giving informed consent. After multivariable analysis, independent predictors of willingness to enroll included Catholic religion (OR 1.57, 95% CI 1.17–2.10) and belief that current therapy offers a >50% chance of full recovery (OR 1.29, 95% CI 1.05–1.57). There was no difference between the proportion willing to enroll in a cardiac arrest study vs. a stroke study (55% vs. 55%, p = 0.83) CONCLUSIONS: Fifty-five percent of ED patients would be willing to be enrolled in a stroke trial using exception from informed consent. |
format | Text |
id | pubmed-3047845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-30478452011-03-03 Public opinion of a stroke clinical trial using exception from informed consent Goldstein, Joshua N. Espinola, Janice A. Fisher, Jonathan Pallin, Daniel J. Camargo, Carlos A. Int J Emerg Med Brief Research Report BACKGROUND: Acute stroke is a leading cause of morbidity and mortality. Clinical trials in stroke are challenging because victims often do not have the capacity to provide informed consent, excluding those patients most likely to benefit from the research. AIM: We evaluated patient willingness to participate in a hypothetical acute stroke trial using an exception from informed consent. METHODS: Consecutive patients presenting to four emergency departments (EDs) underwent structured interviews regarding a hypothetical stroke trial using an exception from informed consent. RESULTS: Of 461 (72% of eligible) participants, 55% (95% CI, 50%–59%) were willing to be enrolled in the hypothetical study without giving informed consent. After multivariable analysis, independent predictors of willingness to enroll included Catholic religion (OR 1.57, 95% CI 1.17–2.10) and belief that current therapy offers a >50% chance of full recovery (OR 1.29, 95% CI 1.05–1.57). There was no difference between the proportion willing to enroll in a cardiac arrest study vs. a stroke study (55% vs. 55%, p = 0.83) CONCLUSIONS: Fifty-five percent of ED patients would be willing to be enrolled in a stroke trial using exception from informed consent. Springer-Verlag 2010-11-10 /pmc/articles/PMC3047845/ /pubmed/21373310 http://dx.doi.org/10.1007/s12245-010-0244-2 Text en © © The Author(s). This article is published with open access at Springerlink.com 2010 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Brief Research Report Goldstein, Joshua N. Espinola, Janice A. Fisher, Jonathan Pallin, Daniel J. Camargo, Carlos A. Public opinion of a stroke clinical trial using exception from informed consent |
title | Public opinion of a stroke clinical trial using exception from informed consent |
title_full | Public opinion of a stroke clinical trial using exception from informed consent |
title_fullStr | Public opinion of a stroke clinical trial using exception from informed consent |
title_full_unstemmed | Public opinion of a stroke clinical trial using exception from informed consent |
title_short | Public opinion of a stroke clinical trial using exception from informed consent |
title_sort | public opinion of a stroke clinical trial using exception from informed consent |
topic | Brief Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047845/ https://www.ncbi.nlm.nih.gov/pubmed/21373310 http://dx.doi.org/10.1007/s12245-010-0244-2 |
work_keys_str_mv | AT goldsteinjoshuan publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent AT espinolajanicea publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent AT fisherjonathan publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent AT pallindanielj publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent AT camargocarlosa publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent |